Over expansion of MSCs in culture causes senescence (the condition or process of deterioration with age. loss of a cell's power of division and growth). A fairly recent and ever growing body of literature can attest to this.
TEMCELL and all other first-generation methods of manufacturing (bone-marrow MSCs etc) have proved that MSCs work (thanks to all who paved the way!), but they cannot produce enough potent and consistent cells on an industrial commercial scale.
https://hotcopper.com.au/threads/in...3595554/page-44?post_id=26539938#.WbzPctOg9zk
No CR on the horizon.... cash runway deep into second half of 2018.
Excellent results from PoC Asthma studies. Which Pharma is lurking in the background?
FOMO will kick-in soon and this will smash through a $1.50 by Christmas.
The growth potential of this stock is ENORMOUS.
$300-500mill MC (but worth $1bn+... )
9 Sept Interview BioInformant Dr Macdonald, page-3
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $34.32M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.0¢ | 18.5¢ | $7.059K | 37.62K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 58798 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 118880 | 1 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |